The influence of repeated arthrocentesis and exercise on matrix metalloproteinase and tumour necrosis factor a activities in normal equine joints

被引:33
作者
Van den Boom, R
Brama, PAJ
Kiers, GH
DeGroot, J
Barneveld, A
Van Weeren, PR
机构
[1] Univ Utrecht, Fac Vet Med, Dept Equine Sci, NL-3508 TC Utrecht, Netherlands
[2] TNO Prevent & Hlth, Gaubius Lab, Leiden, Netherlands
关键词
horse; exercise; arthrocentesis; MMPs; TNF-alpha;
D O I
10.2746/0425164044868602
中图分类号
S85 [动物医学(兽医学)];
学科分类号
0906 ;
摘要
Reasons for performing study: Matrix metalloproteinases (MMPs) and tumour necrosis factor alpha (TNF-alpha) may be useful as biomarkers of joint disease or inflammation. However, activity of both MMPs and TNF-alpha in synovial fluid (SF) may be influenced by nonpathological factors such as arthrocentesis or exercise. Objective: To investigate the influence of repeated arthrocentesis and exercise on MMP and TNF-a activities in SF from normal equine joints. Methods: SF was collected from the left metacarpophalangeal, radiocarpal and tarsocrural joints of 16 horses. Eight of these horses were subsequently subjected to an exercise programme on a treadmill and 8 were box-rested as controls. Arthrocentesis was repeated 14, 14.5, 17 and 24 days after the start of the exercise programme. General MMP and TNF-a activities were determined in SF. Results: Repeated arthrocentesis caused a gradual increase but the exercise regimen no significant increase in MMP activity. There was a significant increase in TNF-a activity in SF collected from horses 2 h after cessation of the exercise programme. Conclusions and potential relevance: When using MMPs as biomarkers for joint disease, at least 14 days should elapse after previous arthrocentesis before subsequent SF collection. Moderate exercise does not increase MMP activity in SF from normal joints and it may be possible to ignore this as a source of error in evaluating MMP activity in diseased joints.
引用
收藏
页码:155 / 159
页数:5
相关论文
共 40 条
[1]   Synovial fluid cytokines and eicosanoids as markers of joint disease in horses [J].
Bertone, AL ;
Palmer, JL ;
Jones, J .
VETERINARY SURGERY, 2001, 30 (06) :528-538
[2]   INDUCTION OF INTRAARTICULAR TUMOR-NECROSIS-FACTOR DURING ACUTE INFLAMMATORY RESPONSES IN EQUINE ARTHRITIS [J].
BILLINGHURST, RC ;
FRETZ, PB ;
GORDON, JR .
EQUINE VETERINARY JOURNAL, 1995, 27 (03) :208-216
[3]   MATRIX METALLOPROTEINASES - A REVIEW [J].
BIRKEDALHANSEN, H ;
MOORE, WGI ;
BODDEN, MK ;
WINDSOR, LJ ;
BIRKEDALHANSEN, B ;
DECARLO, A ;
ENGLER, JA .
CRITICAL REVIEWS IN ORAL BIOLOGY & MEDICINE, 1993, 4 (02) :197-250
[4]   Matrix metalloproteinase-1,-3,-13 and aggrecanase-1 and-2 are differentially expressed in experimental osteoarthritis [J].
Bluteau, G ;
Conrozier, T ;
Mathieu, P ;
Vignon, E ;
Herbage, D ;
Mallein-Gerin, F .
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS, 2001, 1526 (02) :147-158
[5]   Matrix metalloproteinase activity in equine synovial fluid: influence of age, osteoarthritis, and osteochondrosis [J].
Brama, PAJ ;
TeKoppele, JM ;
Beekman, B ;
van Weeren, PR ;
Barneveld, A .
ANNALS OF THE RHEUMATIC DISEASES, 1998, 57 (11) :697-699
[6]  
Chambers MG, 2001, ARTHRITIS RHEUM-US, V44, P1455, DOI 10.1002/1529-0131(200106)44:6<1455::AID-ART241>3.0.CO
[7]  
2-J
[8]  
Chubinskaya S, 1999, LAB INVEST, V79, P1669
[9]   Characterisation of equine matrix metalloproteinase 2 and 9; and identification of the cellular sources of these enzymes in joints [J].
Clegg, PD ;
Burke, RM ;
Coughlan, AR ;
Riggs, CM ;
Carter, SD .
EQUINE VETERINARY JOURNAL, 1997, 29 (05) :335-342
[10]   Matrix metalloproteinases 2 and 9 in equine synovial fluids [J].
Clegg, PD ;
Coughlan, AR ;
Riggs, CM ;
Carter, SD .
EQUINE VETERINARY JOURNAL, 1997, 29 (05) :343-348